embelin has been researched along with Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Devi Daimary, U; Girisa, S; Kumar, A; Kunnumakkara, AB; Parama, D; Verma, E | 1 |
| Ahn, KS; Ko, JH; Lee, SG; Mishra, S; Sethi, G; Shanmugam, MK; Um, JY; Yang, WM | 1 |
| Achkar, IW; Akhtar, S; Khan, AQ; Kuttikrishnan, S; Prabhu, KS; Siveen, KS; Uddin, S | 1 |
| Amireddy, N; Avisetti, DR; Kalivendi, SV | 1 |
| Andree, M; Brinkmann, K; Coutelle, O; Eming, SA; Hacker, UT; Hallek, M; Hornig-Do, HT; Kashkar, H; Krönke, M; Liwschitz, M; Miwa, S; Piekarek, M; Schiffmann, LM; Seeger, JM; Trifunovic, A; Wiesner, RJ; Witt, A | 1 |
| Chaudhary, A; Dhanjal, JK; Grover, A; Kaul, SC; Nigam, N; Sharma, S; Wadhwa, R | 1 |
| Lu, H; Qiao, L; Wang, J; Wang, Y; Zhou, Y | 1 |
5 review(s) available for embelin and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases.
Topics: Benzoquinones; Chronic Disease; Embelia; Heart Diseases; Humans; Neoplasms; Obesity; X-Linked Inhibitor of Apoptosis Protein | 2022 |
The Application of Embelin for Cancer Prevention and Therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Benzoquinones; Biological Products; Drug Synergism; Humans; Neoplasms; Oxidation-Reduction; Signal Transduction | 2018 |
Embelin: a benzoquinone possesses therapeutic potential for the treatment of human cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzoquinones; Cell Proliferation; Embelia; Humans; Neoplasms; Signal Transduction | 2018 |
Embelin and Its Role in Chronic Diseases.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents, Phytogenic; Autoimmune Diseases; Benzoquinones; Chronic Disease; Humans; Hypoglycemic Agents; Neoplasms | 2016 |
3 other study(ies) available for embelin and Neoplasms
| Article | Year |
|---|---|
The mitochondrial effects of embelin are independent of its MAP kinase regulation: Role of p53 in conferring selectivity towards cancer cells.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Benzoquinones; Epithelial Cells; Humans; Neoplasms; p38 Mitogen-Activated Protein Kinases; Tumor Suppressor Protein p53 | 2019 |
Embelin inhibits endothelial mitochondrial respiration and impairs neoangiogenesis during tumor growth and wound healing.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Cell Respiration; Disease Models, Animal; Endothelial Cells; Mice; Mitochondria; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Uncoupling Agents; Wound Healing | 2014 |
Embelin inhibits TNF-α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence.
Topics: ADAM Proteins; ADAM17 Protein; Benzoquinones; Catalytic Domain; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Humans; Ligands; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Neoplasm Metastasis; Neoplasms; Protein Binding; Tumor Stem Cell Assay | 2014 |